Birth Defects Study to Evaluate Pregnancy exposureS (BD-STEPS)
No material or nonsubstantive change to a currently approved collection
No
Regular
01/21/2021
Requested
Previously Approved
02/28/2023
02/28/2023
8,940
8,940
4,433
4,433
44,307
44,307
The purpose of BD-STEPS is to evaluate factors associated with the occurrence of birth defects and stillbirths and ultimately to work to prevent major birth defects and stillbirths associated with maternal risk factors.
We propose to make two non-substantive changes to the currently-approved protocol for the Birth Defects Study To Evaluate Pregnancy exposureS (BD-STEPS).
1. To streamline the process by which women who are eligible are notified of and administered the stillbirth portion of BD-STEPS.
2. To add questions to the BD-STEPS interview to ask women about receipt of a COVID-19 vaccine.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.